Condition
Chronic Rejection
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Terminated1
Unknown1
Withdrawn1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT00261547Phase 1WithdrawnPrimary
Rituximab Treatment to Block HLA Antibodies in Renal Transplant Recipients
NCT00283348CompletedPrimary
New Strategies for Non-invasive Detection of Chronic Allograft Nephropathy
NCT00980967Not ApplicableUnknownPrimary
Predictive Factors for Chronic Rejection in Lung Transplant Recipients: COLT Study
NCT01052259Not ApplicableTerminatedPrimary
Efficacy and Safety of Deoxyspergualin in Renal Transplant Patient With Chronic Rejection
Showing all 4 trials